A Study of Avelumab in Penile Cancer Who Are Unfit for or Have Progressed After Platinum-Based Chemotherapy
Clinical trial NCT03391479 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03391479
- Sponsor
- University Health Network, Toronto
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-15
- Primary completion
- 2026-12-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.